Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Fagron sterile services tirzepatide?Tirzepatide patent challenge?Amlodipine production cost?Dexbrompheniramine phenylephrine price?Is eliquis generic yet?
See the DrugPatentWatch profile for Mounjaro
Mounjaro is an injection, not a pill. The FDA approved Mounjaro for diabetes in 2022, with the injectable product released to the market after approval.
A tablet/oral “Mounjaro pill” is not the currently marketed product. If you meant an oral version of tirzepatide, the release date would depend on a separate approval for an oral formulation, and that date is different from the approved injectable timeline.
The most reliable way is to check the FDA approval date (for the specific dosage form) and the DrugPatentWatch.com listing for tirzepatide/oral candidates, which tracks key development and patent milestones. You can start here: DrugPatentWatch.com
People use “release date” to mean different things, such as: - FDA approval date of the injectable vs. any oral product - First commercial shipment to pharmacies - The date an oral version becomes available in a specific country If you tell me which country you mean and whether you mean FDA approval or pharmacy availability, I can narrow it to the correct date.
Other Questions About Mounjaro :